Details
Stereochemistry | RACEMIC |
Molecular Formula | C22H28NO3 |
Molecular Weight | 354.4626 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 1 |
SHOW SMILES / InChI
SMILES
C[N+]1(C)CCCCC1COC(=O)C(O)(C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=UHUMRJKDOOEQIG-UHFFFAOYSA-N
InChI=1S/C22H28NO3/c1-23(2)16-10-9-15-20(23)17-26-21(24)22(25,18-11-5-3-6-12-18)19-13-7-4-8-14-19/h3-8,11-14,20,25H,9-10,15-17H2,1-2H3/q+1
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094109 Sources: http://www.genome.jp/dbget-bin/www_bget?dr:D01532 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: http://infomeds.net/akabel.html |
Primary | ACABEL Approved UseAcabel (Bevonium methyl sulfate) is parasympatolytic drug with well balanced action on the neuromuscular device. Possesses broncho-and spasmolytic properties. Acabel is indicated for bronchial asthma, peptic ulcer of a stomach and duodenum, pylorospasm, postoperative spastic pains, spastic locks, cholestasia, cholecystitis, cholangitis, postcholecystectomy syndrome, chronic hepatopathy and pancreatitis, various diseases of kidneys and urinary tract. Prenatal and puerperal pains, dysmenorrhea, adnexitis, endometritis, dysfunction of ovaries, tumor of genitalias. |
Sample Use Guides
Form of release of medicine: Acabel: tablets on 50 mg, candles on 30 pieces in packaging. Acabel compositum: tablets (bevonium methyl sulfate — 0,05 g, Dipyronum — 0,25 g); candles (bevonium methyl sulfate — 0,03 g, Dipyronum — 1 g); ampoules on 5 ml (bevonium methyl sulfate — 0,0025 g, Dipyronum — 2,5 g).
Use: Acabel appoint inside 1 — 2 tablet 2 — 3 times a day, candles (only the adult) — on 1 piece 2 — 3 times a day. Intramusculary or intravenously slowly enter on 1/2 — 1 ampoule of an akabel difficult 3 once a day.
Route of Administration:
Other
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QA03AB13
Created by
admin on Fri Dec 15 15:43:08 GMT 2023 , Edited by admin on Fri Dec 15 15:43:08 GMT 2023
|
||
|
WHO-ATC |
A03AB13
Created by
admin on Fri Dec 15 15:43:08 GMT 2023 , Edited by admin on Fri Dec 15 15:43:08 GMT 2023
|
||
|
WHO-VATC |
QA03CA06
Created by
admin on Fri Dec 15 15:43:08 GMT 2023 , Edited by admin on Fri Dec 15 15:43:08 GMT 2023
|
||
|
WHO-ATC |
A03DA03
Created by
admin on Fri Dec 15 15:43:08 GMT 2023 , Edited by admin on Fri Dec 15 15:43:08 GMT 2023
|
||
|
WHO-VATC |
QA03DA03
Created by
admin on Fri Dec 15 15:43:08 GMT 2023 , Edited by admin on Fri Dec 15 15:43:08 GMT 2023
|
||
|
NCI_THESAURUS |
C66880
Created by
admin on Fri Dec 15 15:43:08 GMT 2023 , Edited by admin on Fri Dec 15 15:43:08 GMT 2023
|
||
|
WHO-ATC |
A03CA06
Created by
admin on Fri Dec 15 15:43:08 GMT 2023 , Edited by admin on Fri Dec 15 15:43:08 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
31800
Created by
admin on Fri Dec 15 15:43:08 GMT 2023 , Edited by admin on Fri Dec 15 15:43:08 GMT 2023
|
PRIMARY | |||
|
3024
Created by
admin on Fri Dec 15 15:43:08 GMT 2023 , Edited by admin on Fri Dec 15 15:43:08 GMT 2023
|
PRIMARY | |||
|
33371-53-8
Created by
admin on Fri Dec 15 15:43:08 GMT 2023 , Edited by admin on Fri Dec 15 15:43:08 GMT 2023
|
PRIMARY | |||
|
C73804
Created by
admin on Fri Dec 15 15:43:08 GMT 2023 , Edited by admin on Fri Dec 15 15:43:08 GMT 2023
|
PRIMARY | |||
|
100000085006
Created by
admin on Fri Dec 15 15:43:08 GMT 2023 , Edited by admin on Fri Dec 15 15:43:08 GMT 2023
|
PRIMARY | |||
|
DTXSID0048341
Created by
admin on Fri Dec 15 15:43:08 GMT 2023 , Edited by admin on Fri Dec 15 15:43:08 GMT 2023
|
PRIMARY | |||
|
SUB00794MIG
Created by
admin on Fri Dec 15 15:43:08 GMT 2023 , Edited by admin on Fri Dec 15 15:43:08 GMT 2023
|
PRIMARY | |||
|
34B0471E08
Created by
admin on Fri Dec 15 15:43:08 GMT 2023 , Edited by admin on Fri Dec 15 15:43:08 GMT 2023
|
PRIMARY | |||
|
DB13542
Created by
admin on Fri Dec 15 15:43:08 GMT 2023 , Edited by admin on Fri Dec 15 15:43:08 GMT 2023
|
PRIMARY | |||
|
C000002
Created by
admin on Fri Dec 15 15:43:08 GMT 2023 , Edited by admin on Fri Dec 15 15:43:08 GMT 2023
|
PRIMARY | |||
|
BEVONIUM
Created by
admin on Fri Dec 15 15:43:08 GMT 2023 , Edited by admin on Fri Dec 15 15:43:08 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)